Form 4: Texas Instruments Director Reginald DesRoches Acquires Shares and Stock Options
SEC Form 4 Filing
Director Reginald DesRoches acquired 614 shares of common stock and 2,551 non-qualified stock options in Texas Instruments on January 27, 2025.
Summary
- On January 27, 2025, Reginald DesRoches, a director at Texas Instruments, acquired 614 shares of common stock.
- These shares were acquired at a price of $0, resulting in a direct ownership of 1,783 shares.
- DesRoches also acquired 2,551 non-qualified stock options with an exercise price of $187.03.
- These options become exercisable in four equal installments starting January 27, 2026, and expire on January 27, 2035.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions, which doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The acquisition of shares and stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the stock options suggests a multi-year commitment from the director.
Industry Context
Insider transactions are closely watched as they can provide insights into management's perspective on the company's valuation and future prospects. This transaction is a routine disclosure of such activity.
Comparison to Industry Standards
- Comparing this transaction to similar insider transactions at peer companies like Intel (INTC) or Qualcomm (QCOM) would provide a benchmark for assessing the magnitude and potential significance of this activity.
- Analyzing the vesting schedules and exercise prices relative to the current market price can also offer insights into the perceived value and incentives for the director.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares and stock options as a positive signal, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| 01/27/2025 | Date of transaction: Acquisition of common stock and stock options. |
| 01/27/2026 | First date the stock options become exercisable. |
| 01/27/2035 | Expiration date of the stock options. |
| 01/29/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.